Related Experiment Videos
The value of cancer treatment
1University of Otago Medical School, Dunedin.
The New Zealand Medical Journal
|March 24, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Sensitivity of Bidens laevis L. to mutagenic compounds. Use of chromosomal aberrations as biomarkers of genotoxicity.
Environmental pollution (Barking, Essex : 1987)·2010
A longitudinal study of health related quality of life and utility measures in patients with advanced breast cancer.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2002
A comparison of time trade-off and quality of life measures in patients with advanced cancer.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·1997
Quality of life scales for patients with cancer: how often to administer?
The New Zealand medical journal·1993
Results of the surveillance policy of stage I non-seminomatous germ cell testicular tumours.
British journal of urology·1992
How can we value what is not measured: the need for better data on women's health and primary care.
The New Zealand medical journal·2026
Public support for cancer prevention and care policies in Aotearoa New Zealand: methods of a national survey.
The New Zealand medical journal·2026
Aotearoa New Zealand public strongly support investment in cancer treatment and care services: findings from a national survey.
The New Zealand medical journal·2026
Public support for better controls on lobbying and industry influence in Aotearoa New Zealand: findings from a national survey.
The New Zealand medical journal·2026
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026